case_images: PMC11062772_01
case_images: Preoperative fundus images in OD and OS.
case_images: CRIOPM2024-8746755.001.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.001.jpg
case_images: fig1
case_images: Fundus examination highlighted exudates on the fovea in OD and on the optic nerve in OS (Figure 1).
case_images: Fundus images in OD before pars plana vitrectomy and fundus images in OS after pars plana vitrectomy.
case_images: CRIOPM2024-8746755.002.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.002.jpg
case_images: fig2
case_images: OS was still swollen with overlying inflammatory material (Figure 2). On that day, she received 1 mg of vancomycin and 2.25 mg ceftazidime and amphotericin B 10 microg in OU.
case_images: Repeat fundus images four days later in OD before pars plana vitrectomy and fundus images in OS after pars plana vitrectomy.
case_images: CRIOPM2024-8746755.003.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.003.jpg
case_images: fig3
case_images: Five days after surgery, improvement was noticed in OS (Figures 3 and 4).
case_images: OCT in OD before pars plana vitrectomy and in OS after pars plana vitrectomy.
case_images: CRIOPM2024-8746755.004.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.004.jpg
case_images: fig4
case_images: Five days after surgery, improvement was noticed in OS (Figures 3 and 4).
case_images: Repeat OCT seven days after the second surgery, after pars plana vitrectomy in both eyes.
case_images: CRIOPM2024-8746755.005.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.005.jpg
case_images: fig5
case_images: No vitreous clumps were observed, and retinal lesions showed resolution (Figures 5 and 6).
case_images: Fundus images ten days after the second surgery, after pars plana vitrectomy in both eyes.
case_images: CRIOPM2024-8746755.006.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.006.jpg
case_images: fig6
case_images: No vitreous clumps were observed, and retinal lesions showed resolution (Figures 5 and 6).
case_images: Fundus images 3 months after bilateral pars plana vitrectomy in both eyes.
case_images: CRIOPM2024-8746755.007.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.007.jpg
case_images: fig7
case_images: No inflammation was noted on the slit-lamp examination while fundus examination showed some fibrosis sparing the center of the fovea in OD as well as overlying fibrosis on the optic disc of the OS (Figures 7 and 8).
case_images: OCT 3 months after bilateral pars plana vitrectomy in both eyes.
case_images: CRIOPM2024-8746755.008.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.008.jpg
case_images: fig8
case_images: No inflammation was noted on the slit-lamp examination while fundus examination showed some fibrosis sparing the center of the fovea in OD as well as overlying fibrosis on the optic disc of the OS (Figures 7 and 8).
case_images: Timeline summarizing the patient's case presentation, treatments, and follow-up. Used acronyms: OU = both eyes; OS = left eye; OD = right eye; CBC = complete blood count; CXR = chest X-ray; VA = visual acuity; PPV = pars plana vitrectomy; ANA = antinuclear antibody; HLA = human leukocyte antigen; OCT = optical coherence tomography; PCR = polymerase chain reaction; IOP = intraocular pressure.
case_images: CRIOPM2024-8746755.009.jpg
case_images: PMC11062772_01_CRIOPM2024-8746755.009.jpg
case_images: fig9
case_images: A summary of the patient's case presentation and treatments is presented in the form of a timeline (Figure 9).